RECALL ALERT: Wells Pharmacy Network Recalls Multiple Veterinary Medications Due to Sterility Concerns

Recommended

wells

Wells Pharmacy Network (“WPN”) is voluntarily recalling all sterile human and veterinary products prepared between February 22, 2016 and September 14, 2016, and that remain within expiry (list below) due to the Food and Drug Administration’s (“FDA”) concern over a lack of sterility assurance.

Administration of a drug product intended to be sterile that has microbial contamination may result in infections that may be serious and life-threatening.

The recalled products were used for a variety of indications. NO VIAL OR PORTION OF ANY LOT OF THESE MEDICATIONS HAS BEEN FOUND TO BE NON STERILE. All recalled products have a label that includes the name Wells Pharmacy Network, logo, drug name, and expiration date. If unsure, Customers can call the pharmacy to determine if their product is on the list.  To date, no adverse events have been reported.

WPN takes the utmost care to ensure patient safety. All patients and providers that received any sterile compounded products prepared between February 22, 2016 and September 14, 2016, and that remain within expiry, should take the following actions:

  • Discontinue use of the products;
  • Quarantine any unused product until further instructions are received on how to return the product; and
  • Contact WPN at the Quality hotline at (800) 794-2360 Monday through Friday, between 9:00 am and 6:00 pm EST or email at WPNQuality@wellsrx.com to discuss the return of any unused sterile product.

Customers with questions regarding this recall can contact WPN at the Quality hotline at (800) 794-2360 Monday through Friday between 9:00 am and 6:00 pm EST or email at WPNQuality@wellsrx.com. Customers should contact their physician, healthcare provider, or veterinarian if they have experienced any problems that may be related to using these products. Providers who have dispensed any sterile products prepared between February 22, 2016 and September 14, 2016 to a patient(s) for use outside of the provider’s office should contact the patient(s) to whom product was dispensed and advise the patient(s) of this recall.

Adverse reactions or quality problems experienced with the use of these products in animals may be reported to FDA in the following ways:

This recall is being conducted with the knowledge of and in cooperation with the FDA.

Wells Pharmacy Network specializes in “wellness, anti-aging, weight management, urology, ophthalmology, and veterinary compounding solutions.”

List of VETERINARY products to be recalled:

Drug Lot #
HISTRELIN ACETATE, LYOPHILIZED 5.5MG INJECTABLE 04062016@6
PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE 04082016@7
DETOMIDINE HCL/XYLAZINE (20ML) 10MG/10MG/ML INJECTABLE 04272016@94
MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE 05022016@11
ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 05092016@12
GLUCOSAMINE SULFATE 20% INJECTABLE 05102016@6
PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE 05112016@3
PENTOSAN SODIUM POLYSULFATE 250MG/ML INJECTABLE 05112016@8
METHOCARBAMOL 100MG/ML INJECTABLE 05272016@3
MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE 05272016@5
PENTOSAN SODIUM POLYSULFATE 250MG/ML INJECTABLE 06142016@47
PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE 06152016@1
MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE 06202016@2
METHOCARBAMOL 100MG/ML INJECTABLE 06222016@7
MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE 06232016@27
ESTRONE AQUEOUS 5MG/ML INJECTABLE 06272016@29
ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 06282016@79
ESTRONE AQUEOUS 5MG/ML INJECTABLE 06292016@5
PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE 07072016@7
CYCLOSPORINE (A) OIL SOLUTION – (10ML) 2% OPHTHALMIC 07142016@35
PHENYLEPHRINE HCL – (5ML) 1MG/ML (0.1%) INJECTABLE 07202016@44
ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 08022016@13
CYCLOSPORINE (A) OIL SOLUTION – (10ML) 2% OPHTHALMIC 08022016@20
PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE 08022016@27
DETOMIDINE HCL/XYLAZINE (20ML) 10MG/10MG/ML INJECTABLE 08022016@70
ESTRONE AQUEOUS 5MG/ML INJECTABLE 08022016@8
FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE 08052016@47
FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE 08092016@57
FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE 08112016@7
ESTRONE AQUEOUS 5MG/ML INJECTABLE 08182016@7
MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE 08222016@18

 

For a complete list, including human medications involved in this recall, click here.

Scroll to Top
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter and get the latest cat food recalls, exclusive coupons, and up-to-date info on everything we're up to!